Robert Sewak

Robert Sewak

Auto-generated profile, based on publicly available information

Robert Sewak

Florida Institute of Technology, United States

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 September 2017 in Medical Hypotheses
Verified
Journal Article
Closed access
RSRobert Sewak
Robert Sewak
BTBettina Teng
Bettina Teng
LLLee A. Learman
Lee A. Learman
CHCharles H. Hennekens
Charles H. Hennekens

24 March 2026 in JMIR Preprints
Verified
Preprint
Open access
LSLea Sacca
Lea Sacca
IAIsabella Abraham
Isabella Abraham
PKPanagiota Kitsantas
Panagiota Kitsantas
RSRobert Sewak
Robert Sewak
CYChengwu Yang
Chengwu Yang
CHCharles H. Hennekens
Charles H. Hennekens
BACKGROUND In the United States (US) and worldwide, chronic pain affects a vast number of people and is one of the leading reasons adults seek medical care. In the US, 24.3% of adults reported chronic pain in the past three months in 2023. Chronic pain is defined as lasting three months or longer, significantly disrupting one’s daily functioning and quality of life. Chronic pain can also be accompanied by other conditions, including anxiety and depression. Health care providers should be aware of several limitations in their array of current treatment modalities. While opioid analgesics are used for moderate to severe pain management, they cause many serious adverse effects, including sedation, respiratory depression, and constipation, and a high risk of dependence and addiction. Other pain medications, such as non-opioid analgesics including nonsteroidal anti-inflammatory drugs, adjuvant analgesics, and corticosteroids, similarly cause a range of side effects and organ toxicity. OBJECTIVE We conducted a pilot study to explore the potential role of a non-invasive and safe transdermal audio-based therapeutic system among 24 police professionals aged 21 to 65 years old with chronic pain, and/or associated conditions of migraine, sleep disorders, stress/anxiety, and conventional headaches. METHODS This STROBE-guided pilot study evaluated the feasibility and perceived effectiveness of a self-administered Transdermal Acoustic Pain Suppression (TAPS) intervention among police personnel in West Palm Beach, Florida. Participants completed a flexible 30-day protocol integrated into their work schedules, with data collection spanning five months due to operational constraints. Descriptive and non-parametric analyses indicated patterns of symptom reduction, perceived pain relief, and user satisfaction, supporting the usability of TAPS in this occupational setting. RESULTS Our pilot study findings showed that following therapy, more than one-third of participants (37.5%) experienced condition improvement and half reported reduced symptoms, including notable pain reduction. CONCLUSIONS The findings from this small pilot study support the rationale for larger analytic studies, designed a priori to test the hypothesis. CLINICALTRIAL Not applicable

2 September 2026 in JMIR Formative Research
Verified
Journal Article
Open access
LSLea Sacca
Lea Sacca
IAIsabella Abraham
Isabella Abraham
PKPanagiota Kitsantas
Panagiota Kitsantas
RSRobert Sewak
Robert Sewak
CYChengwu Yang
Chengwu Yang
CHCharles H Hennekens
Charles H Hennekens
Background: In the United States and worldwide, chronic pain affects a vast number of people and is one of the leading reasons adults seek medical care. In the United States, 24.3% of adults reported experiencing chronic pain in the prior 3 months in 2023. Chronic pain is defined as pain that lasts ≥3 months, significantly disrupting one’s daily functioning and quality of life. Chronic pain can also be accompanied by other conditions, including anxiety and depression. Health care providers should be aware of several limitations in their current treatment modalities. Although opioid analgesics are used for moderate to severe pain management, they cause many serious adverse effects, including sedation, respiratory depression, constipation, and a high risk of dependence and addiction. Other pain medications, such as nonopioid analgesics, including nonsteroidal anti-inflammatory drugs, adjuvant analgesics, and corticosteroids, also cause a range of side effects and organ toxicity. Objective: We conducted a single-arm exploratory pilot study to explore the potential role of a noninvasive, transdermal, audio-based therapeutic system among 24 police professionals aged 21 to 65 years with chronic pain and/or associated conditions, including migraine, sleep disorders, stress, anxiety, and conventional headaches. Methods: In this STROBE (Strengthening the Reporting of Observational Studies in Epidemiology)–guided pilot study, we explored the feasibility and perceived effectiveness of a self-administered intervention based on the Transdermal Acoustic Pain Suppression (TAPS) system among police personnel in West Palm Beach, Florida. Participants completed a flexible 30-day protocol integrated into their work schedules, with data collection spanning 5 months due to operational constraints. We used percentages as measures of effect and the chi-square test and Fisher exact test for significance testing. All P values were 2-sided, with a level of significance of .05. Results: In this small pilot study, following TAPS therapy, more than one-third (n=9, 37.5%) of participants experienced improvement in their condition, and half (n=12, 50%) reported reduced symptoms, including notable pain reduction. Conclusions: Although the findings from this small pilot study are preliminary, we believe they support the rationale for larger analytic studies designed a priori to test the hypothesis.